
ACAD Competitors
ACADIA Pharmaceuticals Inc.
$17.11
-$0.48(-2.73%)
50
Overall
75
Value
18
Tech
57
Quality
Market Cap
$2.96B
Volume
1.90M
52W Range
$15.86 - $30.96
Target Price
$30.05
ACAD competitors: VNDA, BMY, PFE, JNJ, LLY. ACADIA Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ACAD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | $3.44 | $221.92M | $-2.53 | - | 34 |
| BMY Bristol-Myers Squibb Company | $58.80 | $119.25B | $6.45 | 4.29% | 61 |
| PFE Pfizer Inc. | $27.40 | $156.97B | $3.05 | 4.71% | 61 |
| JNJ Johnson & Johnson | $270.47 | $643.09B | $11.12 | 1.95% | 62 |
| LLY Eli Lilly and Company | $1347.11 | $1.27T | $35.48 | 0.39% | 63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $17.11 | -2.7% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW